You are here

580b57fcd9996e24bc43c53e   LinkedIn Logo 500x500   Facebook logo square   Iguana Trans cropped

event icon
Date
15.07.19 - 19.07.19
The Moeller Centre, Storey's Way, Cambridge, CB3 0DE

A British Toxicology Society (BTS) and American College of Toxicology event


Introduction

This highly acclaimed course will provide training in toxicology as applied in drug development to scientists from all parts of the World. Participants will obtain an overall understanding of the principles of non-clinical safety evaluation with emphasis on the practical application of these principles and interpretation of non-clinical safety data. Regulatory toxicology in drug development will be emphasised, from both a European and a US perspective. Through the week the students will participate in tutored group study of regulatory cases and original data from a regulatory submission which will conclude with a half-day workshop.

Aim

The course is intended to benefit individuals from biotechnology and pharmaceutical companies working with either small or large molecules, along with those from CROs, regulatory agencies and academia who are interested in toxicology and its application in safety assessment of drugs and medical products and for toxicologists early in their career seeking more in-depth knowledge and understanding of the role of toxicology in safety assessment.  It is also suitable for scientists trained in ancillary disciplines (such as chemistry, biochemistry, molecular biology, medicine, etc.) making a career change to work in drug safety assessment.

Further Details

For further information and to register, please visit the British Toxicology Society website.

Continuing Professional Development (CPD)

This event is approved by the Royal Society of Biology for purposes of CPD and may be counted as 96 CPD credits.

We use cookies: to perform functions such as login and account management; and to track usage with Google analytics to improve our website. To find out more about the cookies we use and how to delete them, see our cookie policy.   I accept cookies from this site.